Saba Capital Management, L.P. - 19 Feb 2026 SCHEDULE 13D/A Report for abrdn Life Sciences Investors Common Shares, $0.01 par value (HQL)

Filing Manager
Saba Capital Management, L.P.
Reporting Manager
Saba Capital Management, L.P.
Security
abrdn Life Sciences Investors Common Shares, $0.01 par value
Symbol
HQL
Shares outstanding
29,579,010 shares
Disclosed Ownership
1,464,161 shares
Ownership
5%
Form type
SCHEDULE 13D/A
Filing time
23 Feb 2026, 17:50:06 UTC
Date of event
19 Feb 2026
Previous filing
11 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Saba Capital Management, L.P. 5% 1,464,161 0 1,464,161 /s/ Michael D'Angelo General Counsel 0001510281
Boaz R. Weinstein 5% 1,464,161 0 1,464,161 /s/ Michael D'Angelo Authorized Signatory 0001608233
Saba Capital Management GP, LLC 5% 1,464,161 0 1,464,161 /s/ Michael D'Angelo Attorney-in-fact*